Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
$8.96+0.11 (+1.19%)
Close on Nov 18, 2026Market cap $3.04BP/E –Yield –
Telix Pharmaceuticals net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -$7.13M, down 121.2% from the year before.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.13M | -121.2% |
| FY2024 | Dec 31, 2024 | $33.69M | +700.5% |
| FY2023 | Dec 31, 2023 | $4.21M | – |
See a number that looks wrong?